quiz 5 (#36-71 - BN, CLASS, & FDA-I)

0.0(0)
studied byStudied by 29 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/107

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

108 Terms

1
New cards

CANDESARTAN (BN)

Atacand, Various

2
New cards

CANDESARTAN (CLASS)

Angiotensin II Receptor Antagonist

3
New cards

CANDESARTAN (FDA-I)

1. Heart failure
2. HTN

4
New cards

CEFDINIR (BN)

Omnicef, Various

5
New cards

CEFDINIR (CLASS)

Third-Generation Cephalosporin

6
New cards

CEFDINIR (FDA-I)

1. Acute otitis media, pharyngitis, tonsillitis
2. Bronchitis, acute secondary bacterial infection
3. Community acquired pneumonia, uncomplicated skin, and/or subcutaneous tissue infectionCOPD, acute exacerbation
4. Streptococcal pharyngitis, group A (alternative agent for mild, nonanaphylactic penicillin allergy)

7
New cards

CEFUROXIME (BN)

Ceftin, Zinacef, Various

8
New cards

CEFUROXIME (CLASS)

Second-Generation Cephalosporin

9
New cards

CEFUROXIME (FDA-I)

1. Acute infective exacerbation of COPD, uncomplicated skin and/or subcutaneous tissue infection, acute bacterial maxillary sinusitis, uncomplicated UTI
2. Acute otitis media
3. Bronchitis, acute, secondary bacterial infection
4. Gonorrhea, uncomplicated
5. Pharyngitis, tonsillitis
6. UTI (alternative agent), acute uncomplicated cystitis, acute simple cystitis
7. Bite wound, prophylaxis, or treatment

10
New cards

CEPHALEXIN (BN)

Keflex, Daxbia, Various

11
New cards

CEPHALEXIN (CLASS)

First-Generation Cephalosporin

12
New cards

CEPHALEXIN (FDA-I)

1. Infection of skin and/or subcutaneous tissue
2. Osteomyelitis
3. Otitis media, respiratory tract infection, UTI
4. Streptococcal pharyngitis
5. Impetigo, ecthyma
6. Cellulitis (nonpurulent), erysipelas

13
New cards

CLINDAMYCIN ORAL (BN)

Cleocin, Various

14
New cards

CLINDAMYCIN ORAL (CLASS)

Lincosamide Antibiotic

15
New cards

CLINDAMYCIN ORAL (FDA-I)

1. Bacterial infectious disease, susceptible infections due to anaerobic organisms, staphylococci, streptococci, pneumococci
2. Infection of skin and/or subcutaneous tissue
3. Infectious disease of abdomen
4. Lower respiratory tract infection
5. Pelvic inflammatory disease
6. Stepticemia
7. Osteomyelitis
8. Diabetic foot infection

16
New cards

DEXLANSOPRAZOLE (BN)

Dexilant

17
New cards

DEXLANSOPRAZOLE (CLASS)

Proton Pump Inhibitor

18
New cards

DEXLANSOPRAZOLE (FDA-I)

1. Erosive esophagitis, treatment
2. Symptomatic gastroesophageal reflux disease

19
New cards

DOXYCYCLINE (BN)

Vibramycin, Doxy 100, Various

20
New cards

DOXYCYCLINE (CLASS)

Tetracycline Antibiotic

21
New cards

DOXYCYCLINE (FDA-I)

1. Acinetobacter infection
2. Acne vulgaris
3. Gonorrhea, uncomplicated
4. Staphylococcal infection of skin
5. Pneumonia, community-acquired, empiric therapy

22
New cards

ERYTHROMYCIN (BN)

Erythrocin, Various

23
New cards

ERYTHROMYCIN (CLASS)

Macrolide Antibiotic

24
New cards

ERYTHROMYCIN (FDA-I)

1. Bacterial infections

25
New cards

ESOMEPRAZOLE (BN)

Nexium, Various

26
New cards

ESOMEPRAZOLE (CLASS)

Proton Pump Inhibitor

27
New cards

ESOMEPRAZOLE (FDA-I)

1. H. pylori GI infection
2. Erosive esophagitis, GERD treatment
3. Erosive esophagitis, heart burn
4. Prevention of NSAID-induced gastopathy
5. Zollinger-Ellison syndrome

28
New cards

FAMOTIDINE (BN)

Pepcid, Various

29
New cards

FAMOTIDINE (CLASS)

Histamine H₂ Antagonist

30
New cards

FAMOTIDINE (FDA-I)

1. Duodenal ulcer, acute
2. Duodenal ulcer, maintenance
3. Gastroesophageal reflux disease (GERD)
4. Gastric ulcer, acute
5. Indigestion, heartburn (OTC)

31
New cards

FELODIPINE (BN)

Plendil, Various

32
New cards

FELODIPINE (CLASS)

Calcium Channel Blocker, Dihydropyridine

33
New cards

FELODIPINE (FDA-I)

1. HTN

34
New cards

FLUTICASONE NASAL (BN)

Flonase, Xhance, Various

35
New cards

FLUTICASONE NASAL (CLASS)

Intranasal Adrenal Glucocorticosteroid

36
New cards

FLUTICASONE NASAL (FDA-I)

1. Allergic nrhinitis
2. Nonallergic rhinitis
3. Nasal polyps

37
New cards

HEPATITIS A VACCINE (BN)

Havrix, Vaqta

38
New cards

HEPATITIS A VACCINE (CLASS)

Vaccine, Inactivated, Viral

39
New cards

HEPATITIS A VACCINE (FDA-I)

1. Hepatitis A prophylaxis

40
New cards

HEPATITIS B VACCINE (BN)

Engerix-B, Recombivax HB

41
New cards

HEPATITIS B VACCINE (CLASS)

Vaccine, Inactivated, Viral

42
New cards

HEPATITIS B VACCINE (FDA-I)

1. Prevention of hepatitis B infection

43
New cards

HUMAN PAPILLOMAVIRUS VACCINE (BN)

Gardasil 9

44
New cards

HUMAN PAPILLOMAVIRUS VACCINE (CLASS)

Vaccine, Inactivated, Viral

45
New cards

HUMAN PAPILLOMAVIRUS VACCINE (FDA-I)

1. Prevention of human papillomavirus infection, cancer and precancerous lesions of the cervix, vulva, vagina, and anus and genital warts

46
New cards

INFLUENZA VIRUS VACCINE (BN)

Afluria, Fluad, Flublok, Fluzone, FluLaval, Fluarix

47
New cards

INFLUENZA VIRUS VACCINE (CLASS)

Vaccine, Inactivated, Viral

48
New cards

INFLUENZA VIRUS VACCINE (FDA-I)

1. Prevention of influenza infection

49
New cards

INSULIN (BN)

Humulin, Various Analogs

50
New cards

INSULIN (CLASS)

Insulin

51
New cards

INSULIN (FDA-I)

1. Diabetes melitus, Type 1 and 2

52
New cards

IRBESARTAN (BN)

Avapro, Various

53
New cards

IRBESARTAN (CLASS)

Angiotensin II Receptor Antagonist

54
New cards

IRBESARTAN (FDA-I)

1. Diabetic nephropathy in patients with diabetes mellitus type 2 and HTN
2. HTN

55
New cards

LANSOPRAZOLE (BN)

Prevacid, Various

56
New cards

LANSOPRAZOLE (CLASS)

Proton Pump Inhibitor

57
New cards

LANSOPRAZOLE (FDA-I)

1. Duodenal ulcer disease
2. Gasteric ucler disease, treatment
3.
H. pylori GI tract infection, triple therapy
4. Erosive esophagitis, GERD, treatment
5. Zollinger-Ellison syndrome

58
New cards

LINAGLIPTIN (BN)

Tradjenta

59
New cards

LINAGLIPTIN (CLASS)

Dipeptidyl Peptidase IV Inhibitor

60
New cards

LINAGLIPTIN (FDA-I)

1. Diabetes mellitus type 2

61
New cards

METFORMIN (BN)

Glucophage, Various

62
New cards

METFORMIN (CLASS)

Biguanide, Hypoglycemic

63
New cards

METFORMIN (FDA-I)

1. Diabetes mellitus type 2
2. Polycystic ovary syndrome

64
New cards

METRONIDAZOLE (BN)

Flagyl, Various

65
New cards

METRONIDAZOLE (CLASS)

Nitroimidazole Antibiotic, Antiprotozoal

66
New cards

METRONIDAZOLE (FDA-I)

1. Abscess, anaerobic
2. Amebic dysentery, acute Bacterial vaginosis
3. Trichomoniasis (for patient and sex partner)

67
New cards

MINOCYCLINE (BN)

Minocin, Various

68
New cards

MINOCYCLINE (CLASS)

Tetracycline Antibiotic

69
New cards

MINOCYCLINE (CLASS)

1. Acne vulgaris
2. Allergy to penicillin-bacterial infectious disease

70
New cards

MOMETASONE NASAL (BN)

Nasonex, Various

71
New cards

MOMETASONE NASAL (CLASS)

Intranasal Corticosteroid

72
New cards

MOMETASONE NASAL (FDA-I)

1. Seasonal and perennial allergic rhinitis
2. Nasal polyp

73
New cards

NIFEDIPINE (BN)

Adalat CC, Procardia XL, Various

74
New cards

NIFEDIPINE (CLASS)

Dihydropyridine Calcium Channel Blocker

75
New cards

NIFEDIPINE (FDA-I)

1. HTN
2. Stable chronic angina
3. Variant angina

76
New cards

OLMESARTAN (BN)

Benicar, Various

77
New cards

OLMESARTAN (CLASS)

Angiotensin II Receptor Antagonist

78
New cards

OLMESARTAN (FDA-I)

1. HTN

79
New cards

PRAVASTATIN (BN)

Pravachol, Various

80
New cards

PRAVASTATIN (CLASS)

HMG-CoA Reductase Inhibitor

81
New cards

PRAVASTATIN (FDA-I)

1. Cerebrovascular accident (prevention), coronary arteriosclerosis (primary or secondary prevention)
2. Familial hypercholesterolemia
3. Hyperlipidemia

82
New cards

QUINAPRIL (BN)

Accupril, Various

83
New cards

QUINAPRIL (CLASS)

ACE-I, Antihypertensive

84
New cards

QUINAPRIL (FDA-I)

1. Heart failure
2. HTN

85
New cards

RAMIPRIL (BN)

Altace, Various

86
New cards

RAMIPRIL (CLASS)

ACE-I, Antihypertensive

87
New cards

RAMIPRIL (FDA-I)

1. Heart failure
2. HTN
3. Reduce risk of myocardial infarction, stroke, and death from cardiovascular causes

88
New cards

ROSUVASTATIN (BN)

Crestor, Ezallor, Various

89
New cards

ROSUVASTATIN (CLASS)

HMG-CoA Reductase Inhibitor

90
New cards

ROSUVASTATIN (FDA-I)

1. Hyperlipidemia
2. Disorder of cardiovascular system, primary prophylaxis, familial hypercholesterolemia, homozygous, hypertriglyceridemia, mixed with dsylipidemia

91
New cards

SAXAGLIPTIN (BN)

Onglyza

92
New cards

SAXAGLIPTIN (CLASS)

Dipeptidyl Peptidase IV Inhibitor, Antidiabetic

93
New cards

SAXAGLIPTIN (FDA-I)

1. Diabetes mellitus

94
New cards

SIMVASTATIN (BN)

Zocor, Various

95
New cards

SIMVASTATIN (CLASS)

HMG-CoA Reductase Inhibitor

96
New cards

SIMVASTATIN (FDA-I)

1. Hyperlipidemia
2. Primary and secodary preventions of atherosclerotic cardiovascular disease
3. Secondary prevention of cardiovascular events
4. Familial hypercholesterolemia (homozygous)

97
New cards

SITAGLIPTIN (BN)

Januvia

98
New cards

SITAGLIPTIN (CLASS)

Dipeptidyl Peptidase IV Inhibitor, Antidiabetic

99
New cards

SITAGLIPTIN (FDA-I)

1. Diabetes mellitus, type 2

100
New cards

TETANUS TOXOID (BN)

Daptacel, Adacel, Boostrix, Infanrix